Global Sales, Higher Value-Added Offerings, and Profitability Improvement
First written in FY2016. 13 of 35 entries say "Advanced", first in FY2017-Q3. Latest entry: 2026-08-10.
9 other companies' latest entry also says "Restated".
- 2026-08-10RestatedRevision of earnings forecasts
「In addition, toward the second half of the fiscal year, we will promote stronger sales of various products, including our core products.」
The Company indicated that it would strengthen sales of various products, including core products, in the second half of the fiscal year and continue efforts to improve earnings through sales expansion. - FY2026Full-year sales and profit decline, lower production suspension costsAnnual report
「The substantial decline in net sales resulted in operating profit of ¥341 million, down 15.1% year on year. Although production suspension costs were limited to ¥139 million, a decrease of ¥33 million from the previous fiscal year, partly because some factories began producing new products, the impact of interest rates also contributed to ordinary profit of ¥128 million, down 26.1%.」
Operating profit and ordinary profit declined because of the substantial decrease in net sales. Meanwhile, production suspension costs fell by ¥33 million as production of new products was introduced. - 2026-05-11WorsenedEarnings
「As a result, total sales reached ¥8,946 million, down ¥764 million year on year, or 7.9%. In terms of profit, operating profit was ¥341 million, down 15.1%, reflecting the substantial decline in sales.」
Company-wide sales and operating profit declined, and performance related to improving the global sales and profit structure deteriorated. - FY2026-H1Sharp sales and profit decline, ordinary lossAnnual report
「In terms of profit, the substantial decline in net sales resulted in operating profit of ¥104 million, down 41.7% year on year. Although improved factory utilization, partly due to newly acquired contract manufacturing products, limited production suspension costs to ¥85 million, a decrease of ¥21 million from the same period of the previous year, the impact of interest rates and foreign exchange movements, among other factors, resulted in an ordinary loss of ¥16 million, compared with ordinary profit of ¥47 million in the same period of the previous year.」
Despite improved factory utilization and lower production suspension costs, operating profit fell 41.7% because of the substantial decline in net sales, and the company reported an ordinary loss. - FY2025Higher revenue, lower operating profit and higher ordinary profitAnnual report
「In terms of profit, the company advanced efforts to pass on increases in costs, including raw material and energy prices. However, various costs rose more than initially expected, and the company was unable to absorb the full increase. Operating profit was ¥402 million, down 16.6% year on year. Meanwhile, improved factory utilization reduced production suspension costs, recorded as non-operating expenses, by ¥107 million from the same period of the previous year to ¥173 million. Ordinary profit was ¥173 million, up 30.7%.」
Net sales increased 5.1%, but operating profit fell 16.6% because price increases did not fully offset higher costs. Meanwhile, ordinary profit increased 30.7% as a result of improved factory utilization and lower production suspension costs. - FY2025-H1Higher sales and lower profit, insufficient price pass-throughAnnual report
「The company promoted price pass-through measures in response to soaring costs, but was unable to absorb the full increase in costs, including raw materials. Operating profit fell 14.9% year on year to ¥179 million. Ordinary profit was ¥47 million, down 37.8%, after ¥107 million in production suspension costs was recorded as a non-operating expense.」
Net sales increased 16.5% year on year, but price increases did not fully offset higher costs, resulting in lower operating profit and ordinary profit. The company also recorded ¥107 million in production suspension costs. - FY2024-Q3Lower sales, higher operating income and lower ordinary incomeAnnual report
「Total sales settled at ¥6,857 million, down ¥502 million year on year and 6.8%. For some products, price revisions improved profitability, while production adjustments at some plants to address stagnant demand resulted in part of the expenses being recorded as production suspension costs. Operating profit consequently rose 6.5% to ¥380 million. Ordinary profit fell 40.5% to ¥108 million after ¥232 million in production suspension costs was recorded as a non-operating expense.」
Price revisions and production adjustments lifted operating profit, but sales fell 6.8% and ordinary profit declined 40.5%. Production suspension costs of ¥232 million were recorded. - FY2024-Q2Lower sales and profit, continued production suspension costsAnnual report
「Total sales settled at ¥4,353 million, down ¥940 million year on year and 17.8%. Although the pass-through of higher prices partially improved profitability, lower sales across product categories, including ultraviolet absorbers, and elevated manufacturing costs caused operating profit to fall 38.0% to ¥211 million. Ordinary profit was ¥76 million, down 63.6%, after ¥104 million in production suspension costs was recorded as a non-operating expense.」
Although price pass-through led to a partial improvement, company-wide sales fell 17.8%, operating profit declined 38.0% and ordinary profit fell 63.6%. Production suspension costs of ¥104 million were also recorded. - FY2024-Q1Sharp sales and profit decline, ordinary lossAnnual report
「Lower sales of ultraviolet absorbers, weak performance by high-margin contract-manufactured products and elevated manufacturing costs caused operating profit to fall 88.0% year on year to ¥25 million. Ordinary loss was ¥19 million after ¥31 million in production suspension costs was recorded as a non-operating expense, compared with ordinary profit of ¥162 million in the same quarter of the previous year.」
Weak performance by core products and contract-manufactured products, together with elevated manufacturing costs, caused operating profit to fall 88.0% and ordinary profit to turn into an ordinary loss from a profit in the year-earlier period. - FY2023Higher sales and lower profit, higher manufacturing costsAnnual report
「Total sales settled at ¥9,760 million, up ¥16 million year on year and 0.2%. Although the company continued to proactively acquire contract-manufactured products, lower sales of ultraviolet absorbers and other products, together with a sharp increase in manufacturing costs, caused operating profit to fall 35.2% to ¥357 million. Ordinary profit fell 54.2% to ¥121 million after ¥176 million in production suspension costs was recorded as a non-operating expense.」
The company continued to acquire contract-manufactured products, but lower sales of its core products and higher manufacturing costs resulted in higher sales but lower profit overall. - FY2023-Q3Revenue Growth and Profit DeclineAnnual report
「Total sales settled at ¥7,360 million, up ¥137 million year on year and 1.9%. Although the company continued to proactively acquire contract-manufactured products, lower sales of ultraviolet absorbers and other products, together with a sharp increase in manufacturing costs, caused operating profit to fall 29.2% to ¥356 million. Ordinary profit fell 40.5% to ¥181 million after ¥135 million in production suspension costs was recorded as a non-operating expense.」
The company continued to acquire contract-manufactured products, but lower sales of ultraviolet absorbers and other products and higher manufacturing costs resulted in higher sales but lower profit overall. - FY2023-Q2Revenue Growth and Profit DeclineAnnual report
「Although the company continued to increase sales of ultraviolet absorbers and other products and proactively acquire contract-manufactured products, operating profit fell 18.6% year on year to ¥340 million. Ordinary profit declined 23.8% to ¥210 million after ¥99 million in production suspension costs was recorded as a non-operating expense.」
Despite continued higher sales of ultraviolet absorbers and other products and the acquisition of contract-manufactured products, operating profit fell 18.6% and ordinary profit declined 23.8%, partly due to ¥99 million in production suspension costs. - FY2023-Q1Revenue Growth and Profit DeclineAnnual report
「In addition to higher sales of ultraviolet absorbers and other products, the company continued its proactive acquisition of contract-manufactured products. Operating profit fell 13.0% year on year to ¥210 million, while ordinary profit declined 0.5% to ¥162 million after ¥32 million in production suspension costs was recorded as a non-operating expense.」
The company continued to increase sales and acquire contract-manufactured products, but operating profit fell 13.0% and ordinary profit declined 0.5%. Production suspension costs of ¥32 million were also recorded. - FY2022AdvancedAnnual report
「In addition to a recovery in sales of ultraviolet absorbers, the continued proactive acquisition of contract-manufactured products lifted operating profit 58.3% year on year to ¥552 million. Ordinary profit rose 138.8% to ¥264 million despite ¥217 million in production suspension costs recorded as a non-operating expense.」
A recovery in sales of ultraviolet absorbers and the acquisition of contract-manufactured products led to significant improvements in operating profit and ordinary profit. Production suspension costs of ¥217 million were still recorded. - FY2022-Q3AdvancedAnnual report
「In addition to a recovery in sales of ultraviolet absorbers, the continued proactive acquisition of contract-manufactured products lifted operating profit 60.2% year on year to ¥503 million. Ordinary profit rose 115.0% to ¥305 million despite ¥150 million in production suspension costs recorded as a non-operating expense.」
A recovery in sales of ultraviolet absorbers and the acquisition of contract-manufactured products lifted operating profit 60.2% year on year and ordinary profit 115.0%. Production suspension costs of ¥150 million continued to be recorded. - FY2022-Q2AdvancedAnnual report
「Total sales settled at ¥4,813 million, up ¥553 million year on year and 13.0%, despite a ¥204 million decline resulting from the adoption of the revenue recognition accounting standard and related standards. A recovery in sales of ultraviolet absorbers and the continued proactive acquisition of contract-manufactured products lifted operating profit 105.5% to ¥418 million. Ordinary profit rose 179.5% to ¥276 million despite ¥107 million in production suspension costs recorded as a non-operating expense.」
A recovery in sales of ultraviolet absorbers and the proactive acquisition of contract-manufactured products lifted sales, operating profit and ordinary profit above the year-earlier levels. - FY2022-Q1AdvancedAnnual report
「In addition to a recovery in sales of ultraviolet absorbers, the continued proactive acquisition of contract-manufactured products lifted operating profit 159.2% year on year to ¥241 million. Ordinary profit rose 241.7% to ¥162 million despite ¥60 million in production suspension costs recorded as a non-operating expense.」
A recovery in sales of ultraviolet absorbers and the acquisition of contract-manufactured products lifted operating profit 159.2% year on year and ordinary profit 241.7%. - FY2021Full-Year Revenue and Profit DeclineAnnual report
「The company offset the impact of lower sales through the acquisition of contract-manufactured products and expense reductions, but operating profit fell 9.8% year on year to ¥349 million. Ordinary profit declined 31.6% to ¥110 million after ¥176 million in production suspension costs was recorded as a non-operating expense.」
The acquisition of contract-manufactured products and expense reductions offset lower sales, but operating profit and ordinary profit declined. Operating performance related to improving the earnings structure shifted from progress to deterioration. - FY2021-Q3AdvancedAnnual report
「The company offset the impact of lower sales through the proactive acquisition of contract-manufactured products and expense reductions. Operating profit rose 6.3% year on year to ¥314 million. Ordinary profit rose 0.7% to ¥141 million despite ¥133 million in production suspension costs recorded as a non-operating expense.」
Despite a 9.3% decline in company-wide sales, operating profit rose 6.3% and ordinary profit increased 0.7% due to the acquisition of contract-manufactured products and expense reductions. Production suspension costs of ¥133 million continued. - FY2021-Q2Securing profit despite lower salesAnnual report
「The company offset lower sales through the proactive acquisition of contract-manufactured products and expense reduction efforts, securing operating profit of ¥203 million, down 3.7% year on year.」
The acquisition of contract-manufactured products and expense reductions offset lower sales, but operating profit still fell 3.7% year on year. - FY2021-Q1AdvancedAnnual report
「Although sales declined, operating profit rose 26.9% year on year to ¥93 million due to the benefits of improved plant utilization and other factors. Ordinary profit rose 127.3% to ¥47 million, despite ¥31 million in production suspension costs recorded as a non-operating expense, down 30.3% year on year.」
Despite lower sales, operating profit rose 26.9% year on year and ordinary profit increased 127.3% due to the benefits of improved plant utilization and other factors. Production suspension costs also fell 30.3% year on year. - FY2020AdvancedAnnual report
「Sales rose 13.0% year on year to ¥10,596 million. Operating profit increased 18.7% to ¥386 million, driven by the effect of higher sales. Ordinary profit rose 103.7% to ¥161 million after production suspension costs were recorded as a non-operating expense due to continued production adjustments.」
Company-wide sales, operating profit and ordinary profit all exceeded the year-earlier levels, indicating progress in operating performance related to improving the earnings structure. Production suspension costs, however, continued. - FY2020-Q3AdvancedAnnual report
「Total sales rose by ¥751 million year on year to ¥7,616 million, up 11.0%. Operating profit increased 47.9% to ¥295 million, driven by the effect of higher sales. Ordinary profit rose 611.4% to ¥140 million after ¥120 million in production suspension costs was recorded as a non-operating expense due to continued production adjustments.」
Company-wide sales rose 11.0% year on year, operating profit increased 47.9% and ordinary profit rose 611.4%. Production suspension costs of ¥120 million associated with production adjustments continued. - FY2020-Q2AdvancedAnnual report
「Total sales rose by ¥387 million year on year to ¥5,178 million, up 8.1%. Operating profit increased 30.5% to ¥211 million, driven by the effect of higher sales. Ordinary profit rose 289.5% to ¥112 million after ¥76 million in production suspension costs was recorded as a non-operating expense due to continued production adjustments.」
Company-wide sales rose 8.1% year on year, operating profit increased 30.5% and ordinary profit rose 289.5%. Production suspension costs of ¥76 million associated with continued production adjustments remained, but profitability improved from the decline seen through the previous quarter. - FY2020-Q1Higher revenue and lower earningsAnnual report
「Reducing inventories of ultraviolet absorbers, which had been building since the fiscal year before last, became an urgent priority, and continued production adjustments kept manufacturing costs elevated. Price competition also weighed on results, causing operating profit to fall 19.9% year on year to ¥73 million. Ordinary profit fell 44.0% to ¥20 million after ¥44 million in production suspension costs associated with the shutdown of a plant was recorded as a non-operating expense.」
Sales increased, but profit declined due to production adjustments to reduce inventories of ultraviolet absorbers, elevated manufacturing costs, price competition and production suspension costs. - FY2019-Q3Lower revenue and sharp profit declinesAnnual report
「In addition to lower sales, manufacturing costs rose due to production adjustments resulting from elevated raw material prices and higher inventories, while price competition also weighed on results. Operating profit fell 42.2% year on year to ¥200 million. Ordinary profit fell 92.7% to ¥19 million after ¥133 million in production suspension costs associated with the shutdown of a plant was recorded as a non-operating expense.」
Elevated raw material prices, production adjustments due to higher inventories, price competition and plant shutdown costs led to significant declines in operating profit and ordinary profit. - FY2019-Q2Lower revenue and sharp profit declinesAnnual report
「In addition to lower sales, manufacturing costs rose due to production adjustments resulting from elevated raw material prices and higher inventories, while price competition also weighed on results. Operating profit fell 42.8% year on year to ¥162 million. Ordinary profit fell 87.9% to ¥28 million after ¥101 million in production suspension costs associated with the shutdown of a plant was recorded as a non-operating expense.」
Elevated raw material prices, production adjustments due to higher inventories and price competition led to significant declines in operating profit and ordinary profit. Operating performance related to global sales, higher value-added products and improvements in the earnings structure deteriorated. - FY2019-Q1Lower sales and lower operating incomeAnnual report
「As the domestic and overseas economies evolved, the fine chemicals industry in which we operate continued to face a difficult sales and earnings environment. Raw material prices remained volatile due to fluctuations in crude oil prices and foreign exchange rates, while price competition remained intense amid changes in global production systems and other factors.」
Against a backdrop of intensifying price competition due to changes in global production systems, the company reported lower sales and profit in the first quarter, indicating a deterioration in operating performance related to improving its earnings structure. - FY2018Full-year sales growth and profit decline, higher raw material costsAnnual report
「However, higher manufacturing costs resulting from surging raw material prices caused operating profit to fall 18.8% year on year to ¥367 million, ordinary profit to decline 23.3% to ¥274 million, and net profit to decrease 36.2% to ¥192 million.」
Sales increased, but operating profit, ordinary profit and net profit all declined as manufacturing costs rose due to surging raw material prices. - FY2018-Q3Deterioration in profitabilityAnnual report
「However, continued severe price competition and raw material price trends affected profitability, with operating profit falling 17.6% year on year to ¥345 million and ordinary profit declining 21.9% to ¥273 million.」
Sales increased, but operating profit and ordinary profit declined year on year due to price competition and raw material prices. - FY2018-Q2AdvancedAnnual report
「Against this backdrop, during the first half of the fiscal year, sales of our core product, ultraviolet absorbers, declined mainly due to lower sales volumes, while sales of most other chemicals, including photographic chemical intermediates, increased, resulting in higher sales for the Chemicals segment as a whole. The Home Industries segment also reported a slight increase in sales, bringing total sales up by ¥440 million year on year to ¥4,986 million, up 9.7%. With no significant changes in price competition or raw material price trends, strong sales of photographic chemical intermediates, existing electronic materials and other products, including contract-manufactured products, lifted operating profit 4.5% to ¥283 million and ordinary profit 2.3% to ¥238 million.」
Strong sales of photographic chemical intermediates, existing electronic materials and contract-manufactured products drove year-on-year growth of 9.7% in sales and 4.5% in operating profit. - FY2018-Q1AdvancedAnnual report
「With no significant changes in price competition or raw material price trends, operating profit rose 5.2% year on year to ¥139 million, while ordinary profit fell 0.7% to ¥114 million.」
Operating profit rose 5.2% year on year in the first quarter, while ordinary profit fell 0.7%. The figures indicate progress in improving the earnings structure, particularly at the operating profit level. - FY2017AdvancedAnnual report
「Despite continuing global price competition, operating profit rose 98.7% year on year to ¥452 million, driven by higher sales of high-margin products and reductions in various expenses.」
Full-year operating profit rose 98.7% year on year to ¥452 million, driven by higher sales of high-margin products and expense reductions. - FY2017-Q3AdvancedAnnual report
「Despite continuing global price competition, operating profit rose 130.0% year on year to ¥419 million, driven by higher sales of high-margin products and reductions in various expenses. Ordinary profit rose 283.5% to ¥349 million, partly because production suspension costs fell by ¥17 million year on year to ¥25 million.」
Higher sales of high-margin products and expense reductions led to significant year-on-year improvements in operating profit and ordinary profit. - FY2016First statedAnnual report
「We will seek to expand earnings by actively strengthening global sales and developing high-value-added businesses. By implementing management strategies aimed at improving our earnings structure, including productivity improvements, we will secure appropriate profits, continue to pay stable dividends and strengthen retained earnings.」
The company is pursuing overseas market development, high-value-added businesses and productivity improvements as means of expanding earnings and improving its earnings structure.